Abstract
Bckground and Aim: Acute-on-chronic liver failure (ACLF) defines an abrupt and life-threatening worsening of clinical conditions in patients with cirrhosis or chronic liver disease. APASL defines ACLF as an acute hepatic insult manifesting as jaundice (total bilirubin >5 mg/dl) and coagulopathy (INR of >1.5) complicated within 4 weeks by clinical ascites, encephalopathy or both in patients with compensated cirrhosis (diagnosed or undiagnosed) or non-cirrhotic chronic liver disease. Serum ferritin, an acute phase reactant is a known marker of hepatic necro-inflammation and has been studied to predict 1-year mortality in decompensated cirrhotics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
